BIOMAT Database Logo BIOMAT Database Logo

Effect of phospholipid on factor VIII inactivation. 1984

T W Barrowcliffe, and G Kemball-Cook, and E Gray

UI MeSH Term Description Entries
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D005164 Factor IX Storage-stable blood coagulation factor acting in the intrinsic pathway of blood coagulation. Its activated form, IXa, forms a complex with factor VIII and calcium on platelet factor 3 to activate factor X to Xa. Deficiency of factor IX results in HEMOPHILIA B (Christmas Disease). Autoprothrombin II,Christmas Factor,Coagulation Factor IX,Plasma Thromboplastin Component,Blood Coagulation Factor IX,Factor 9,Factor IX Complex,Factor IX Fraction,Factor Nine,Factor IX, Coagulation
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin
D015949 Factor IXa Activated form of factor IX. This activation can take place via the intrinsic pathway of blood coagulation by the action of factor XIa and calcium, or via the extrinsic pathway by the action of factor VIIa, thromboplastin, and calcium. Factor IXa serves to activate factor X to Xa by cleaving the arginyl-leucine peptide bond in factor X. Coagulation Factor IXa,Factor IX, Activated,Blood Coagulation Factor IX, Activated,Factor 9A,Factor Nine A,Activated Factor IX,Factor IXa, Coagulation

Related Publications

T W Barrowcliffe, and G Kemball-Cook, and E Gray
Effect of phospholipid on factor VIII coagulant activity and coagulant antigen.
June 1983, Thrombosis research,
T W Barrowcliffe, and G Kemball-Cook, and E Gray
Inactivation of factor VIII by factor IXa.
March 1992, Biochemistry,
T W Barrowcliffe, and G Kemball-Cook, and E Gray
Activation, activity and inactivation of factor VIII in factor VIII products.
May 2016, Haemophilia : the official journal of the World Federation of Hemophilia,
T W Barrowcliffe, and G Kemball-Cook, and E Gray
Inactivation of HIV in factor VIII.
April 1998, The Medical journal of Australia,
T W Barrowcliffe, and G Kemball-Cook, and E Gray
Altered properties of phospholipid-bound factor VIII.
March 1984, Thrombosis research,
T W Barrowcliffe, and G Kemball-Cook, and E Gray
Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles.
August 1992, The Journal of biological chemistry,
T W Barrowcliffe, and G Kemball-Cook, and E Gray
Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII.
June 2011, Thrombosis and haemostasis,
T W Barrowcliffe, and G Kemball-Cook, and E Gray
Effect of metal cations on the conformation and inactivation of recombinant human factor VIII.
October 2004, Journal of pharmaceutical sciences,
T W Barrowcliffe, and G Kemball-Cook, and E Gray
The mechanism of factor VIII inactivation by human antibodies. II. The effect of factor VIII R: antigen on the rate of interaction.
January 1985, Annals of clinical and laboratory science,
T W Barrowcliffe, and G Kemball-Cook, and E Gray
The inactivation of factor VIII in vitro.
February 1972, Thrombosis et diathesis haemorrhagica,
Copied contents to your clipboard!